Durect Corp (DRRX)
1.07
-0.06
(-5.31%)
USD |
NASDAQ |
May 10, 16:00
1.07
0.00 (0.00%)
After-Hours: 20:00
Durect Enterprise Value: 22.05M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 22.05M |
| May 08, 2024 | 18.64M |
| May 07, 2024 | 24.23M |
| May 06, 2024 | 24.23M |
| May 03, 2024 | 22.98M |
| May 02, 2024 | 17.71M |
| May 01, 2024 | 16.99M |
| April 30, 2024 | 16.77M |
| April 29, 2024 | 16.59M |
| April 26, 2024 | 15.89M |
| April 25, 2024 | 15.41M |
| April 24, 2024 | 14.40M |
| April 23, 2024 | 13.16M |
| April 22, 2024 | 11.97M |
| April 19, 2024 | 14.02M |
| April 18, 2024 | 15.23M |
| April 17, 2024 | 14.23M |
| April 16, 2024 | 11.24M |
| April 15, 2024 | 11.68M |
| April 12, 2024 | 10.75M |
| April 11, 2024 | 12.44M |
| April 10, 2024 | 12.94M |
| April 09, 2024 | 13.21M |
| April 08, 2024 | 14.93M |
| April 05, 2024 | 15.90M |
| Date | Value |
|---|---|
| April 04, 2024 | 18.95M |
| April 03, 2024 | 22.67M |
| April 02, 2024 | 19.88M |
| April 01, 2024 | 21.43M |
| March 28, 2024 | 24.54M |
| March 27, 2024 | 28.57M |
| March 26, 2024 | 26.40M |
| March 25, 2024 | 25.81M |
| March 22, 2024 | 22.47M |
| March 21, 2024 | 24.90M |
| March 20, 2024 | 25.81M |
| March 19, 2024 | 22.78M |
| March 18, 2024 | 27.93M |
| March 15, 2024 | 26.11M |
| March 14, 2024 | 28.54M |
| March 13, 2024 | 21.26M |
| March 12, 2024 | 21.87M |
| March 11, 2024 | 17.62M |
| March 08, 2024 | 17.62M |
| March 07, 2024 | 16.71M |
| March 06, 2024 | 16.64M |
| March 05, 2024 | 16.41M |
| March 04, 2024 | 17.92M |
| March 01, 2024 | 16.75M |
| February 29, 2024 | 17.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.311M
Minimum
Dec 20 2023
697.56M
Maximum
Dec 31 2019
200.91M
Average
148.51M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.645M |
| Palatin Technologies Inc | 28.44M |
| iBio Inc | 16.42M |
| Theriva Biologics Inc | -13.29M |
| Oragenics Inc | 4.605M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.441M |
| Revenue (Quarterly) | 2.669M |
| Total Expenses (Quarterly) | 8.923M |
| EPS Diluted (Quarterly) | -0.13 |
| Gross Profit Margin (Quarterly) | 75.35% |
| Profit Margin (Quarterly) | -53.99% |
| Earnings Yield | -116.8% |
| Normalized Earnings Yield | -148.49 |